IB Acquisition Corp. Right

GNQ Insilico Inc., an AI and quantum computing-focused drug discovery company, announced a definitive business combination agreement with IB Acquisition Corp. (Nasdaq: IBAC). The transaction values GNQ at US$500 million and is expected to close in Q3 2026, with the combined company listing on Nasdaq. GNQ will provide approximately US$15 million i...